Feb. 13, 2001
     Prostate Cancer

 

SUBSCRIBE FREE


Cancer Digest by keyword

Browse Archives
by cancer site

n Lung

n Breast

n Prostate

n Bladder

n Leukemia

n Lymphoma

n Colon

n Cervical/Uteri

n Ovarian

n Pancreatic

n Rare cancers

n News/Issues

 About Us Front Page  Subscribe  Archives  Contact Us

Researchers investigate magnetic treatment for prostate cancer

IOWA CITY, IA -- Feb. 12, 2001 (Cancer Digest)-- A new approach using heat generated from implanted magnetic rods to treat prostate cancer is showing promise in early clinical trials say researchers. The hope is that the new technique will be as successful as surgery and radiation therapy in treating the disease, but will spare patients the side effects of those standard treatments.

The treatment involves implanting small magnetic alloy rods into the prostate using methods similar to those used in brachytherapy to implant radioactive seeds. When the patient with implanted rods is placed in an external, alternating magnetic field, the rods heat up and transfer the heat to the surrounding tissue. The heat from the rods delivers a one-two punch to tumor cells. The heat causes proteins in the cells to denature or unravel, and it coagulates the blood supply, causing tumor cells to die.

"Our results, and those of our international collaborators, suggest that these rods could be extremely effective in treating the cancer with potentially fewer side effects," said lead investigator Dr. Robert D. Tucker, in a prepared statement.

Tucker, who is associate professor of pathology at the University of Iowa, says his collaborators at the Charité Hospital in Berlin, Germany, and the University of Chile in Santiago have produced promising results in early clinical trials.

"Another advantage of these permanent rods is that, unlike radiation treatment, thermal therapy can be repeated non-invasively if the patient's serum PSA values start to rise again," he says. "We think that this approach could also prove useful against other localized tumors."

The U.S. Food and Drug Administration recently approved a clinical study, now under way at University of California San Francisco, aimed at treating prostate cancer patients who have failed radiation treatment.

Tucker's team uses rods made of cobalt and palladium developed by Ablation Technologies of San Diego, Calif. to be biocompatible, which has not been true of materials tested for this purpose in the past. Each cylindrical rod is 1.4 centimeters (1/2 in.) long and 1 millimeter (.04 in.) in diameter.

Using a long hollow needle the physician places the rods in a pattern surrounding the tumor in a relatively simple procedure that takes about 45 minutes The patient receives only a spinal anesthetic and can undergo an initial treatment in the magnetic field the same day and go home.

Scientists have known for decades that certain alloys (mixtures of metals) heat up in a magnetic field to a specific temperature, determined by the composition of the alloy, and maintain that temperature while they remain in the magnetic field.

"Different alloys have different Curie temperatures, which is the temperature at which the alloy goes from being magnetic to nonmagnetic," says Tucker, who also serves on Ablation Technology's board of directors.

"When the rod is magnetic, it heats up in a magnetic field. At the Curie temperature, the rod becomes nonmagnetic and ceases to heat up and it simply maintains the Curie temperature as long as it remains in the magnetic field."

The research team has conducted a series of laboratory experiments to test the properties of the rods and have confirmed the rods are capable of producing enough heat to achieve a uniform temperature increase throughout the tumor and destroy tissue. Each rod has a power output of half a watt, so an array of 60 rods, as might be used in the prostate, would generate as much heat as a 30-watt light bulb.

"Our experiments have shown that when the rods are arranged in arrays, the heat or power is concentrated between the rods. The heating only extends a few millimeters beyond the outside edge of the array," Tucker said. "This means you can place the rods close to the edge of the prostate and minimize the risk of damaging tissue beyond the gland."

The magnetic field used to activate the rods is low and not commonly found in everyday life, thus the risk of inadvertent heating of these permanent implants is very small. Also, the strength of the magnetic field used drops off sharply with increased distance from the coil generating the field. This means that magnetic objects in a patient's body that are more than about 8 in. away will not heat up. A metal hip replacement however, is an example of a magnetic implant that would present a problem for using this treatment.

Last year more than 180,000 men in the United States were diagnosed with prostate cancer. When the cancer is confined to the prostate gland, surgical removal of the prostate, or radiation therapy are the two most commonly recommended treatment options. Although both these methods offer good odds for success, they each entail risks of damage to the tissue around the prostate, which in turn can cause incontinence and impotence.
    


Prepared by:
     Cancer Digest
     (206) 525-7725
     Last modified: 13-Feb.-01
Top of Page | Home | Search | Contact Us|
The information in this server is provided as a courtesy by the Cancer Digest in Seattle, Washington, USA. © 1999 Cancer Digest Please see the Cancer Digest Disclaimer.
-----------------------------172352945329450 Content-Disposition: form-data; name="userfile"; filename="" 1